If you're searching "lion's mane vs cordyceps," the short answer is: they are optimizing for different things, and stacking both without a clear goal is the most expensive way to stay confused. Lion's mane targets cognition and neurological support via nerve growth factor pathways; cordyceps targets aerobic energy metabolism and exercise tolerance via ATP-adjacent mechanisms. This article breaks down the mechanism of each, what human clinical trials actually show (and what is still only animal data), how dosing and timing differ, what drug interactions each carries, and a plain-language use-case guide for choosing one, the other, or both. You'll also get specific guidance on what to look for on product labels, because the sourcing gap between quality and filler is significant for both mushrooms.
Summary: quick answer on lion's mane vs cordyceps
Lion's mane has better-defined human RCT evidence for cognitive support in older adults, and a plausible neurotrophin mechanism; cordyceps has preliminary human data for aerobic performance, but the two key trials are small and use different species. Neither claim is settled at scale.
Best for lion's mane:
- Adults experiencing cognitive fog, early memory concerns, or age-related concentration decline
- People in high-cognitive-load work wanting daily neuroprotective support
- Anyone whose primary interest is neurological, not athletic
Best for cordyceps:
- Endurance athletes or recreational runners wanting to explore an ATP/oxygen-utilization supplement
- People already managing stress and cognition well who want to address physical performance specifically
- Anyone comfortable working with moderate-quality evidence and a low side-effect profile
Not ideal for lion's mane:
- People on anticoagulant medications (minor but documented interaction risk)
- Anyone with a known mushroom allergy (case reports of allergic reaction exist)
- Those expecting rapid cognitive change (the Mori 2009 RCT showed effects at 16 weeks, not days)
Not ideal for cordyceps:
- People on anticoagulants, immunosuppressants, or blood-glucose-lowering medications (documented interaction categories)
- Anyone who needs certainty from large replicated human RCTs before trialing a supplement
- Those looking primarily for cognitive or neurological support rather than physical performance
Decision shortcut: If your concern is cognitive, choose lion's mane. If your concern is aerobic capacity or physical stamina, cordyceps is the more mechanistically relevant choice. If you have both concerns, a sequential trial (one at a time, 8 weeks each) gives you a cleaner read than stacking from day one.
What you'll find in this guide
- How each one works: mechanism side by side
- What the RCT evidence actually shows
- The cordyceps species problem
- Dosing: what clinical trials used
- When to take both vs either
- Side effects and drug interactions
- Product picks
- Frequently asked questions
- Conclusion: the bottom line on lion's mane vs cordyceps
How each one works: mechanism side by side
Lion's mane: nerve growth factor and myelin support
Lion's mane (Hericium erinaceus, family Hericiaceae) is a culinary and medicinal mushroom native to North America, Europe, and Asia. Its proposed cognitive mechanism centers on two classes of bioactive compounds: hericenones (found in the fruiting body) and erinacines (found in the mycelium). Both have been shown in cell culture and rodent studies to stimulate the synthesis and secretion of nerve growth factor (NGF), a neurotrophin essential for the growth, maintenance, and survival of neurons.
Think of NGF's role like fertilizer for an existing plant rather than a transplant. The neurons are already there; the question is whether they're getting enough trophic support to maintain dendritic connections and myelination. Lion's mane doesn't create new neurons from scratch, but the in vitro and animal data suggest it may support the maintenance conditions neurons need. The clinical translation of this mechanism is where the evidence gets more cautious.
A key pharmacokinetic note: hericenones and erinacines have different molecular profiles and potentially different blood-brain-barrier penetration. Products made entirely from mycelium may differ meaningfully in bioactive compound profile from fruiting-body-only products. This is relevant when comparing trial evidence to commercial products.
Actionable takeaway: Lion's mane's proposed mechanism is neurological, not metabolic. Don't expect it to increase physical energy or athletic output; the target is cognitive maintenance and neuroprotection.
Cordyceps: ATP synthesis and aerobic oxygen utilization
Cordyceps has a fundamentally different proposed mechanism. The theoretical primary target is cellular energy metabolism. Cordycepin (3'-deoxyadenosine), the key active compound, is structurally similar to adenosine and is proposed to influence ATP synthesis pathways at the mitochondrial level. Separately, cordyceps extracts have been investigated for effects on oxygen utilization, specifically VO2max and lactate threshold in aerobic exercise contexts.
Unlike lion's mane's neurological target, cordyceps is working at the energy-production layer. This is why proponents position it for physical rather than cognitive performance. But the caveat is real: most of the mechanistic detail is in vitro or animal-based, and the human trial evidence is smaller in volume and sample size than the cordyceps marketing ecosystem implies.
The NCCIH cordyceps overview acknowledges traditional use of cordyceps in Tibetan and Chinese medicine while noting that high-quality clinical evidence in humans remains limited as of their most recent update.
What the RCT evidence actually shows
Lion's mane: two key human trials, both in older adults
The two most-cited human RCTs for lion's mane are honest starting points, but both have important scope limitations.
A 2009 double-blind, placebo-controlled RCT (Mori et al., n=30) recruited older Japanese adults (mean age 65) with mild cognitive impairment. Participants received 250mg of dried Hericium erinaceus fruiting body three times daily (750mg total) for 16 weeks. The treatment group showed statistically significant improvements on the Revised Hasegawa Dementia Scale versus placebo at weeks 8, 12, and 16. The effect was moderate and reversed within 4 weeks of stopping supplementation. The n=30 size and specific MCI population limit how broadly this finding generalizes to healthy younger adults seeking cognitive optimization.
A 2019 pilot RCT (Saitsu et al., n=31) in adults aged 50-80 found that lion's mane supplement use for 12 weeks was associated with improved Mini-Mental State Examination (MMSE) scores versus control. The study was small and had methodological limitations, but directionally consistent with Mori 2009.
For the proposed NGF mechanism, the supporting evidence remains primarily in vitro and rodent-based. A frequently cited foundational paper on erinacine-stimulated NGF synthesis (Kawagishi and Zhuang, 2008) used cell-culture models. This in vitro work supports the biological plausibility of the mechanism, but the real question isn't whether lion's mane stimulates NGF in a petri dish; it's whether the human oral dose achieves meaningful central nervous system concentrations to replicate that effect. That translation step remains incompletely characterized in humans.
A separate 2010 RCT (Nagano et al., n=30) found improvements in depression and anxiety scores in menopausal women taking lion's mane for 4 weeks, suggesting possible mood effects, though this was not a cognitive-performance study.
Actionable takeaway: The strongest human evidence for lion's mane targets cognitive decline in older adults, not cognitive enhancement in healthy young adults. If you're 30 and looking for a productivity boost, the clinical evidence supporting that specific use case is weaker than the marketing implies.
Cordyceps: two key human RCTs, different species, different populations
The human evidence base for cordyceps' athletic-performance claims rests primarily on two trials that require careful reading.
A 2010 RCT (Chen et al., n=20, PMID 20566740) examined a Cordyceps sinensis-derived supplement (Cs-4/CordyMax, a mycelium fermentation extract) on metabolic markers and exercise capacity in elderly subjects over 12 weeks. The study found improvements in several aerobic-performance measures including VO2max versus placebo. The limitations are significant: n=20, elderly population, and the extract used was Cordyceps sinensis, not the Cordyceps militaris that most commercial products now use. The Cs-4 extract is also a patented preparation unlikely to match the bioactive profile of generic commercial militaris products.
A 2017 double-blind, placebo-controlled RCT (Hirsch et al., n=28, PMID 27408987) is the more methodologically relevant modern trial. It used Cordyceps militaris whole powder at 4g per day versus placebo in recreationally active adults over three weeks. The treatment group showed a statistically significant increase in VO2max (approximately +11% versus +1.8% placebo) at week 3. This is the most directly applicable finding for a consumer considering a militaris-based product. The trial was small and short, and the effect size warrants replication in larger samples before strong conclusions.
Preliminary human data suggest cordyceps may support aerobic capacity, though larger trials are needed before this becomes a reliable clinical recommendation.
The cordyceps species problem
This is not a footnote, it is a central purchasing issue, and it matters specifically in the lion's mane vs cordyceps comparison because lion's mane doesn't have the same sourcing problem.
The original Cordyceps sinensis (Ophiocordyceps sinensis) is a parasitic fungus found on ghost moth larvae at altitude in the Tibetan Plateau. Wild-harvested supply is tiny and the price is prohibitive (up to $20,000 per kilogram). It is essentially unavailable in any meaningful dose in mainstream retail supplements.
Almost every product labeled "cordyceps" uses Cordyceps militaris, a different though related cultivated species. This is not inherently a problem; Hirsch 2017 used militaris and found a meaningful VO2max effect. But within the militaris category, a further distinction matters: many commercial products use mycelium grown on grain substrate rather than fruiting-body-derived extracts. Grain-substrate mycelium products can have a substantial proportion of their weight as starch filler, diluting the actual fungal bioactive content.
An adaptogen brand can have impressive marketing and still miss third-party testing for the active marker compound. For cordyceps, that marker is cordycepin content. Fruiting-body militaris extracts with a disclosed and verified cordycepin percentage are most likely to match what was tested in Hirsch 2017.
For lion's mane, the equivalent purchasing concern is fruiting body versus mycelium sourcing: hericenones are primarily in the fruiting body, erinacines primarily in the mycelium. Neither is strictly superior, but products should specify which part they contain and whether beta-glucan content is standardized. "Lion's mane root powder" on a label tells you nothing about what's actually active in the capsule.
Dosing: what clinical trials used
Lion's mane dosing from trials
In the Mori 2009 MCI trial, participants took 250mg of dried Hericium erinaceus fruiting-body powder three times daily for 16 weeks, totaling 750mg per day. In the Saitsu 2019 pilot, a similar daily dose range was used over 12 weeks. Most commercial lion's mane products deliver 500mg to 1g per serving, and given the Mori 2009 dose of 750mg/day as the primary human RCT reference point, products in this range are reasonably aligned with the trial protocol.
Look for products that specify fruiting body (not "lion's mane extract" without source clarification), and that disclose beta-glucan or erinacine content where possible. Without standardization labeling, "lion's mane powder" alone tells you nothing about active-compound concentration.
Cordyceps dosing from trials
In the Hirsch 2017 militaris trial, the dose was 4g per day of whole Cordyceps militaris powder taken in divided doses over three weeks. In the Chen 2010 sinensis trial, Cs-4 was used at 333mg three times daily (999mg total). The difference is significant: most commercial cordyceps capsule products deliver 500mg to 1g per serving, which is well below the 4g per day used in the most directly relevant human trial. People evaluating whether a commercial militaris product is "dosed appropriately" relative to the trial evidence should check total daily dose, not just per-capsule dose.
When to take both vs either
Most articles on lion's mane vs cordyceps treat this as a binary choice. The honest answer is more specific: the combination is reasonable only if you have a clear reason for each.
Take lion's mane alone if your primary concern is cognition, memory, or neuroprotection. The cordyceps mechanism adds nothing to that use case.
Take cordyceps alone if your primary concern is aerobic performance and physical stamina. Lion's mane's NGF pathway is irrelevant to VO2max or lactate threshold.
Consider both together if you have genuine and concurrent needs in both domains: you're an older adult (50+) managing early cognitive concerns who also wants to maintain aerobic fitness. The two mushrooms have no known pharmacological interaction, and their mechanisms are complementary rather than redundant. A combination product exists (Host Defense makes a lion's mane + cordyceps blend), though individual products give you dose control that combination pills often don't.
Don't combine on faith because a supplement brand recommends it, or because you've read they "work synergistically." No RCT has tested the combination. Traditional use is not the same as RCT evidence.
| Your primary complaint | Suggested starting point |
|---|---|
| Cognitive fog, memory, concentration | Lion's mane (fruiting body, 750mg+/day, 12-16 weeks) |
| Aerobic fatigue, reduced exercise capacity | Cordyceps (militaris fruiting body, toward 4g/day, 3-6 weeks) |
| Both cognitive and physical concerns | Sequential trial: 8 weeks lion's mane, then add cordyceps |
| Neither confirmed need | Neither: fix sleep, nutrition, and training volume first |
Side effects and drug interactions
Lion's mane: generally well-tolerated, minor anticoagulant concern
In clinical trials, lion's mane at studied doses has a favorable safety profile. The Mori 2009 trial reported no serious adverse events in the 16-week protocol. The most commonly reported adverse effect is gastrointestinal discomfort (nausea, loose stools) at higher doses.
Drug interactions (lion's mane): Per Memorial Sloan Kettering's integrative herbs database on lion's mane:
- Anticoagulants (warfarin, heparin, clopidogrel): Lion's mane has demonstrated mild platelet-aggregation inhibitory activity in laboratory studies. The clinical significance in humans is not well-characterized, but people taking anticoagulant medications should consult their prescriber before adding lion's mane. The risk is considered minor compared to many herbals, but it is real.
- Mushroom allergies: Case reports of allergic respiratory reactions to lion's mane exist, including at least one case of occupational asthma in a mushroom farmer. People with known mushroom allergies should exercise caution.
Pregnancy and breastfeeding: No adequate safety data. Standard caution applies: do not use during pregnancy or while breastfeeding without explicit physician guidance.
Cordyceps: anticoagulant, immunosuppressant, and blood glucose interactions
In the Hirsch 2017 trial, Cordyceps militaris was well-tolerated, with no serious adverse events in the 28-participant cohort. Gastrointestinal discomfort at higher doses is the most commonly reported user complaint.
Drug interactions (cordyceps): Per Memorial Sloan Kettering's integrative herbs database on cordyceps:
- Anticoagulants (warfarin, heparin, clopidogrel): Cordyceps has demonstrated platelet-aggregation inhibition in laboratory studies. Combined use with anticoagulants may increase bleeding risk. People taking blood thinners should not use cordyceps without explicit medical clearance.
- Immunosuppressants (tacrolimus, cyclosporine, biologics): Cordyceps has immunomodulatory properties, including potential immune-stimulating effects. This creates a contraindication for organ-transplant recipients or anyone on immunosuppressive therapy, where unintended immune activation can trigger rejection episodes.
- Blood-glucose-lowering medications (insulin, metformin, sulfonylureas): Some animal evidence suggests hypoglycemic activity; clinical significance in humans is not established, but people managing diabetes pharmacologically should monitor glucose levels and consult their prescriber if adding cordyceps.
Pregnancy and breastfeeding: Safety data are absent. Do not use without explicit guidance from a physician.
Actionable takeaway: Cordyceps carries more documented interaction categories than lion's mane. If you are on anticoagulants, immunosuppressants, or diabetes medications, cordyceps is the higher-risk choice of the two. Neither mushroom is interaction-free.
Product picks
For lion's mane, the clearest link to the clinical evidence is a fruiting-body-sourced extract with disclosed beta-glucan content and third-party potency verification. Real Mushrooms and Host Defense are the two brands with the most consistent fruiting-body sourcing documentation.
For cordyceps, the most trial-relevant form is a whole Cordyceps militaris fruiting-body powder or extract with cordycepin content disclosed. At 4g/day being the relevant trial dose, products should be evaluated by their daily-dose delivery at that threshold, not just per-serving size.
For a comprehensive look at the full landscape of medicinal mushrooms, including reishi, turkey tail, and chaga alongside lion's mane and cordyceps, see our complete guide to medicinal mushrooms.
Frequently asked questions
Can I take lion's mane and cordyceps together?
There is no known pharmacological interaction between lion's mane and cordyceps. Some people with concurrent cognitive and athletic goals do stack them, reasoning that the two mechanisms don't overlap. But no clinical trial has tested the combination, and starting with one at a time makes it easier to attribute any effects (or adverse reactions) before adding the second. If budget is a constraint, identifying your primary concern first narrows the choice.
How long before lion's mane shows cognitive effects?
The Mori 2009 RCT found statistically significant cognitive improvement at week 8, with continued benefit through week 16. The Saitsu 2019 pilot used a 12-week protocol. A reasonable minimum trial for cognitive endpoints is 12 weeks at an appropriate fruiting-body dose. Expecting noticeable results in two or three weeks is not aligned with the trial timelines.
Does lion's mane work for anxiety or depression?
The Nagano 2010 pilot RCT (PMID 20834180) found improvements in mood and sleep quality in menopausal women over 4 weeks. This suggests a possible mood effect, though the study was small (n=30) and targeted a specific population. The mechanism proposed involves reduction in nervous system irritation rather than direct serotonergic action. For clinically diagnosed anxiety or depression, lion's mane is not a substitute for evaluated medical treatment.
What cordyceps dose matches the clinical trials?
The Hirsch 2017 militaris trial used 4g per day of whole Cordyceps militaris powder. Most commercial capsule products deliver 500mg-1g per serving. To approach the trial dose, you'd typically need 4-8 capsules per day depending on capsule size. Check total daily dose against that 4g benchmark, not just per-capsule content.
Which is better for brain fog specifically?
Lion's mane is the more mechanistically relevant choice for cognitive fog, given its proposed NGF pathway and the Mori 2009 RCT findings. Cordyceps addresses physical energy metabolism, not neurological maintenance. That said, aerobic exercise itself is one of the most evidence-backed interventions for cognitive function, so improving physical exercise capacity with cordyceps could have secondary cognitive benefits. The direct cognitive mechanism is lion's mane's territory.
Are there mushroom supplements that combine both?
Yes. Host Defense makes a combined lion's mane and cordyceps product. The convenience tradeoff is fixed dosing: you can't independently adjust the lion's mane dose and cordyceps dose. If you're trying to match the Mori 2009 lion's mane dose (750mg/day) and approach the Hirsch 2017 cordyceps dose (4g/day), a combination capsule is unlikely to deliver adequate amounts of each. Separate products give more precise dose control.
Conclusion: the bottom line on lion's mane vs cordyceps
Lion's mane and cordyceps are regularly grouped as the "top two" functional mushrooms, but they are not competing for the same outcome. Lion's mane targets cognition and neurological maintenance through proposed NGF stimulation, with the most relevant human evidence in older adults with mild cognitive impairment. Cordyceps targets aerobic energy metabolism and oxygen utilization, with the most relevant human evidence in recreationally active adults using Cordyceps militaris at 4g per day.
The sourcing issue matters for both: fruiting-body sourcing and compound standardization are the differentiating factors between products likely to match clinical trial profiles and products unlikely to match them. For cordyceps specifically, the sinensis-vs-militaris species distinction is a purchasing question that requires a label check.
Drug-interaction profiles differ in meaningful ways. Lion's mane carries a minor anticoagulant concern. Cordyceps carries anticoagulant, immunosuppressant, and blood-glucose interaction risks, making it the higher-caution choice if you are on any of those medication classes.
For a deeper look at how lion's mane performs in longer-term cognitive protocols, see our dedicated article on lion's mane for nerve regeneration and cognitive support. For the full picture on cordyceps and physical performance, see our article on cordyceps for energy.
Next steps:
- If cognitive support is your primary goal, our lion's mane complete guide covers dosing protocols, product selection criteria, and what the full evidence base looks like across MCI, mood, and neurotrophin research.
- If you're comparing cordyceps to another adaptogen in the energy-and-endurance space, our article on rhodiola vs cordyceps covers the HPA-axis vs aerobic-metabolism distinction in detail.
- If you want to understand both mushrooms within the broader functional mushroom landscape, our complete guide to medicinal mushrooms is the place to start.
As an Amazon Associate, I earn from qualifying purchases. Product recommendations are based on real reviews and independent research.
This article is for informational purposes and not medical advice. Lion's mane and cordyceps are functional mushrooms classified as dietary supplements; neither has received FDA approval for the treatment of any medical condition. Cordyceps may interact with anticoagulants, immunosuppressants, and blood-glucose-lowering medications. Lion's mane may interact with anticoagulants. Consult a licensed physician before starting either supplement, particularly if you are pregnant, nursing, taking prescription medications, or managing a chronic condition.
As an Amazon Associate, I earn from qualifying purchases. Product recommendations are based on real reviews and independent research.
This article is for informational purposes and not medical advice. Herbal adaptogens, even traditional ones, can interact with thyroid medication, antidepressants, anticoagulants, immunosuppressants, blood-pressure drugs, and more. Consult a licensed physician before starting any adaptogen, particularly if you are pregnant, nursing, taking prescription medications, or managing a chronic condition.
